当前位置:首页 - 行情中心 - 药石科技(300725) - 财务分析 - 现金流量表

药石科技

(300725)

  

流通市值:110.24亿  总市值:127.14亿
流通股本:2.03亿   总股本:2.34亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,120,256,084.74495,133,341.922,150,578,302.711,545,415,387.34
  收到的税费返还32,398,355.4415,598,164.7848,860,466.1539,125,824.58
  收到其他与经营活动有关的现金12,821,708.4210,399,302.6425,386,373.9421,584,658.5
  经营活动现金流入小计1,165,476,148.6521,130,809.342,224,825,142.81,606,125,870.42
  购买商品、接受劳务支付的现金459,763,114.46204,066,735.81742,137,695.73461,685,552.17
  支付给职工以及为职工支付的现金399,199,703.46207,186,870.89620,770,920.6479,635,079.19
  支付的各项税费56,742,061.6926,416,136.66102,289,991.3570,952,074.89
  支付其他与经营活动有关的现金57,421,869.7727,278,523.1992,265,705.850,370,559.46
  经营活动现金流出小计973,126,749.38464,948,266.551,557,464,313.481,062,643,265.71
  经营活动产生的现金流量净额192,349,399.2256,182,542.79667,360,829.32543,482,604.71
二、投资活动产生的现金流量:
  收回投资收到的现金1,382,790,308.36447,847,646.793,926,728,808.222,219,896,932.13
  取得投资收益收到的现金9,010,145.024,022,264.0543,917,706.9313,930,353.78
  处置固定资产、无形资产和其他长期资产收回的现金净额638,077.24372,758.83,273,678.36183,565.74
  投资活动现金流入小计1,392,438,530.62452,242,669.643,973,920,193.512,234,010,851.65
  购建固定资产、无形资产和其他长期资产支付的现金177,131,061.2690,017,060.2140,130,434.8358,136,575.46
  投资支付的现金1,199,735,154.8560,257,475.024,010,591,095.72,483,581,394.51
  投资活动现金流出小计1,376,866,216.06650,274,535.224,150,721,530.532,541,717,969.97
  投资活动产生的现金流量净额15,572,314.56-198,031,865.58-176,801,337.02-307,707,118.32
三、筹资活动产生的现金流量:
  取得借款收到的现金--100,000,000100,000,000
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--100,000,000100,000,000
  偿还债务支付的现金--275,007,357.22275,007,357.22
  分配股利、利润或偿付利息支付的现金66,476,223.72543,715.4865,746,095.4769,489,134.34
  支付其他与筹资活动有关的现金518,729.7296,613.191,705,613.382,675,327.73
  筹资活动现金流出小计66,994,953.42840,328.67342,459,066.07347,171,819.29
  筹资活动产生的现金流量净额-66,994,953.42-840,328.67-242,459,066.07-247,171,819.29
四、汇率变动对现金及现金等价物的影响-25,986,216.73-14,438,270.38-5,561,795.491,465,968.39
五、现金及现金等价物净增加额114,940,543.63-157,127,921.84242,538,630.74-9,930,364.51
  加:期初现金及现金等价物余额532,739,255.18532,739,255.18290,200,624.44290,200,624.44
  期末现金及现金等价物余额647,679,798.81375,611,333.34532,739,255.18280,270,259.93
补充资料:
  净利润99,444,867.74-183,735,514.39-
  资产减值准备20,414,876.52-50,382,275.75-
  固定资产和投资性房地产折旧70,517,836.47-131,214,349.87-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧70,517,836.47-131,214,349.87-
  无形资产摊销2,987,586.76-5,810,689.86-
  长期待摊费用摊销2,761,827.82-4,312,822.09-
  处置固定资产、无形资产和其他长期资产的损失-84,715.95--1,148,940.44-
  固定资产报废损失2,089,017.05-2,469,194.97-
  公允价值变动损失-4,662,794.52--678,192.97-
  财务费用23,561,606.13-38,340,714.16-
  投资损失-11,428,551.66--36,281,193.53-
  递延所得税3,680,953.52--8,194,479.68-
  其中:递延所得税资产减少3,230,950.56--7,174,804.03-
    递延所得税负债增加450,002.96--1,019,675.65-
  存货的减少-79,582,263.62-154,327,730.88-
  经营性应收项目的减少27,598,493.62-162,084,373.58-
  经营性应付项目的增加32,271,074.02--15,268,135.25-
  其他211,077.36--6,503,454.75-
  现金的期末余额647,679,798.81-532,739,255.18-
  减:现金的期初余额532,739,255.18-290,200,624.44-
  现金及现金等价物的净增加额114,940,543.63-242,538,630.74-
公告日期2026-08-112026-04-222026-04-222025-10-30
审计意见(境内)标准无保留意见
TOP↑